1 |
M |
LVGLMWLSY |
88 |
96 |
10 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
2 |
M |
ATSRTLSYY |
173 |
181 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
3 |
M |
FVLAAVYRI |
65 |
73 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
4 |
M |
ATSRTLSYY |
173 |
181 |
11 |
HLA-A*03:01 |
100% (SARS-CoV) |
5 |
M |
TSRTLSYYK |
174 |
182 |
10 |
HLA-A*03:01 |
100% (SARS-CoV) |
6 |
M |
LWPVTLACF |
57 |
65 |
10 |
HLA-A*24:02 |
100% (SARS-CoV) |
7 |
M |
SYFIASFRL |
95 |
103 |
9 |
HLA-A*24:02 |
88.89% (SARS-CoV) |
8 |
M |
ATSRTLSYY |
173 |
181 |
9 |
HLA-A*26:01 |
100% (SARS-CoV) |
9 |
M |
SELVIGAVI |
136 |
144 |
10 |
HLA-B*40:01 |
100% (SARS-CoV) |
10 |
M |
KLIFLWLLW |
50 |
58 |
10 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
11 |
M |
MACLVGLMW |
85 |
93 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
12 |
M |
ATSRTLSYY |
173 |
181 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
13 |
M |
ATSRTLSYY |
173 |
181 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
14 |
E |
SVLLFLAFV |
16 |
24 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
15 |
E |
FLAFVVFLL |
20 |
28 |
10 |
HLA-A*02:01 |
100% (SARS-CoV) |
16 |
E |
FLLVTLAIL |
26 |
34 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
17 |
E |
YVYSRVKNL |
57 |
65 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
18 |
E |
LLFLAFVVF |
18 |
26 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
19 |
N |
SSPDDQIGY |
79 |
87 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
20 |
N |
SPDDQIGYY |
80 |
88 |
10 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
21 |
N |
DLSPRWYFY |
104 |
112 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
22 |
N |
LSPRWYFYY |
105 |
113 |
9 |
HLA-A*01:01 |
100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (OC43), 88.89% (HKU1) |
23 |
N |
KTFPPTEPK |
366 |
374 |
10 |
HLA-A*03:01 |
100% (SARS-CoV) |
24 |
N |
DLSPRWYFY |
104 |
112 |
10 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
25 |
N |
SPRWYFYYL |
106 |
114 |
9 |
HLA-B*07:02 |
100% (SARS-CoV), 88.89% (OC43), 88.89% (HKU1) |
26 |
N |
SPRWYFYYL |
106 |
114 |
9 |
HLA-B*08:01 |
100% (SARS-CoV), 88.89% (OC43), 88.89% (HKU1) |
27 |
N |
QRNAPRITF |
9 |
17 |
10 |
HLA-B*27:05 |
88.89% (SARS-CoV) |
28 |
N |
KMKDLSPRW |
101 |
109 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
29 |
N |
LSPRWYFYY |
105 |
113 |
10 |
HLA-B*58:01 |
100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (OC43), 88.89% (HKU1) |
30 |
S |
STECSNLLL |
756 |
764 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
31 |
S |
LLFNKVTLA |
832 |
841 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
32 |
S |
VVFLHVTYV |
1075 |
1083 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
33 |
S |
TLADAGFIK |
838 |
846 |
9 |
HLA-A*03:01 |
88.89% (SARS-CoV) |
34 |
S |
VLKGVKLHY |
1282 |
1290 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
35 |
S |
PYRVVVLSF |
514 |
522 |
9 |
HLA-A*24:02 |
100% (SARS-CoV) |
36 |
S |
IAIPTNFTI |
722 |
730 |
9 |
HLA-A*24:02 |
88.89% (SARS-CoV), 88.89% (HKU1) |
37 |
S |
WTFGAGAAL |
898 |
908 |
9 |
HLA-A*26:01 |
100% (SARS-CoV) |
38 |
S |
VRFPNITNL |
331 |
339 |
9 |
HLA-B*27:05 |
100% (SARS-CoV) |
39 |
S |
YQPYRVVVL |
512 |
520 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
40 |
S |
WTFGAGAAL |
898 |
906 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
41 |
S |
AEIRASANL |
1030 |
1038 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
42 |
S |
KEIDRLNEV |
1197 |
1205 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
43 |
S |
IAIPTNFTI |
722 |
730 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV), 88.89% (HKU1) |
44 |
S |
FAMQMAYRF |
910 |
918 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
45 |
S |
YIKWPWYIW |
1226 |
1234 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV), 88.89% (MERS-CoV) |
46 |
Leade |
KSFDLGDEL |
143 |
151 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
47 |
NSP2 |
YTRYVDNNF |
184 |
192 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
48 |
NSP2 |
YTRYVDNNF |
184 |
192 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
49 |
NSP2 |
YTRYVDNNF |
184 |
192 |
9 |
HLA-B*15:01 |
88.89% (SARS-CoV) |
50 |
NSP2 |
TLSEQLDFI |
217 |
225 |
9 |
HLA-A*02:01 |
88.89% (SARS-CoV) |
51 |
NSP2 |
HEHEIAWYT |
237 |
245 |
9 |
HLA-B*40:01 |
88.89% (SARS-CoV) |
52 |
NSP2 |
YELQTPFEI |
252 |
260 |
9 |
HLA-B*40:01 |
88.89% (SARS-CoV) |
53 |
NSP2 |
FMGRIRSVY |
300 |
308 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
54 |
NSP2 |
FMGRIRSVY |
300 |
308 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
55 |
NSP2 |
EIAIILASF |
478 |
486 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
56 |
NSP3 |
KTLQPVSEL |
893 |
901 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
57 |
NSP3 |
KLTDNVYIK |
1047 |
1055 |
9 |
HLA-A*03:01 |
88.89% (SARS-CoV) |
58 |
NSP3 |
DIQLLKSAY |
1143 |
1151 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
59 |
NSP3 |
QEILGTVSW |
1384 |
1392 |
9 |
HLA-B*40:01 |
88.89% (SARS-CoV) |
60 |
NSP3 |
ILGTVSWNL |
1386 |
1394 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
61 |
NSP3 |
YMSALNHTK |
1669 |
1677 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
62 |
NSP3 |
MSALNHTKK |
1670 |
1678 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
63 |
NSP3 |
GEAANFCAL |
1729 |
1737 |
9 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
64 |
NSP3 |
GEAANFCAL |
1729 |
1737 |
9 |
HLA-B*40:01 |
88.89% (SARS-CoV) |
65 |
NSP3 |
KRVLNVVCK |
1769 |
1777 |
9 |
HLA-B*27:05 |
100% (SARS-CoV) |
66 |
NSP3 |
VQQESPFVM |
1823 |
1831 |
9 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
67 |
NSP3 |
HITSKETLY |
1864 |
1872 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
68 |
NSP3 |
HITSKETLY |
1864 |
1872 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
69 |
NSP3 |
TTIKPVTYK |
1901 |
1909 |
9 |
HLA-A*03:01 |
88.89% (SARS-CoV) |
70 |
NSP3 |
KPASRELKV |
1976 |
1984 |
9 |
HLA-B*07:02 |
88.89% (SARS-CoV) |
71 |
NSP3 |
KPVETSNSF |
2045 |
2053 |
9 |
HLA-B*07:02 |
88.89% (SARS-CoV) |
72 |
NSP3 |
HTDLMAAYV |
2121 |
2129 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
73 |
NSP3 |
VQMAPISAM |
2405 |
2413 |
9 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
74 |
NSP3 |
VQMAPISAM |
2405 |
2413 |
9 |
HLA-B*15:01 |
88.89% (SARS-CoV) |
75 |
NSP3 |
QMAPISAMV |
2406 |
2414 |
9 |
HLA-A*02:01 |
88.89% (SARS-CoV) |
76 |
NSP3 |
APISAMVRM |
2408 |
2416 |
9 |
HLA-B*07:02 |
88.89% (SARS-CoV) |
77 |
NSP3 |
SHFVNLDNL |
2555 |
2563 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
78 |
NSP3 |
TPRDLGACI |
2722 |
2730 |
9 |
HLA-B*07:02 |
100% (SARS-CoV) |
79 |
NSP3/ |
MSLSEQLRK |
2757 |
2765 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
80 |
NSP4 |
AAKKNNLPF |
2771 |
2779 |
9 |
HLA-B*15:01 |
88.89% (SARS-CoV) |
81 |
NSP4 |
CFANKHADF |
2866 |
2874 |
9 |
HLA-A*24:02 |
88.89% (SARS-CoV) |
82 |
NSP4 |
LLFLMSFTV |
3127 |
3135 |
9 |
HLA-A*02:01 |
88.89% (SARS-CoV) |
83 |
NSP4 |
LFLMSFTVL |
3128 |
3136 |
9 |
HLA-B*08:01 |
88.89% (SARS-CoV) |
84 |
NSP4 |
LMSFTVLCL |
3130 |
3180 |
9 |
HLA-A*02:01 |
88.89% (SARS-CoV) |
85 |
NSP4 |
SVIYLYLTF |
3150 |
3158 |
9 |
HLA-A*24:02 |
88.89% (SARS-CoV) |
86 |
NSP4 |
SVIYLYLTF |
3150 |
3158 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
87 |
NSP4 |
SVIYLYLTF |
3150 |
3158 |
9 |
HLA-B*15:01 |
88.89% (SARS-CoV) |
88 |
NSP4 |
VIYLYLTFY |
3151 |
3159 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
89 |
NSP4 |
VIYLYLTFY |
3151 |
3159 |
9 |
HLA-A*03:01 |
88.89% (SARS-CoV) |
90 |
NSP4 |
VSFLAHIQW |
3164 |
3172 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
91 |
NSP4 |
FLLNKEMYL |
3227 |
3236 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
92 |
NSP4 |
FLLNKEMYL |
3228 |
3236 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
93 |
NSP4 |
RYLALYNKY |
3251 |
3259 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 88.89% (OC43), 88.89% (HKU1) |
94 |
NSP4 |
ALYNKYKYF |
3254 |
3262 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
95 |
NSP4 |
ALYNKYKYF |
3254 |
3262 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
96 |
3C-li |
CAMRPNFTI |
3439 |
3447 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
97 |
3C-li |
GSVGFNIDY |
3457 |
3465 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
98 |
3C-li |
VSFCYMHHM |
3468 |
3476 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
99 |
3C-li |
FCYMHHMEL |
3470 |
3478 |
9 |
HLA-B*08:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
100 |
3C-li |
SAQTGIAVL |
3567 |
3575 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
101 |
NSP6 |
DEFTPFDVV |
3602 |
3610 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
102 |
NSP6 |
QSTQWSLFF |
3647 |
3655 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
103 |
NSP6 |
QSTQWSLFF |
3647 |
3655 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
104 |
NSP6 |
STQWSLFFF |
3648 |
3656 |
9 |
HLA-A*24:02 |
100% (SARS-CoV) |
105 |
NSP6 |
TQWSLFFFL |
3649 |
3657 |
9 |
HLA-A*02:01 |
88.89% (SARS-CoV) |
106 |
NSP6 |
TQWSLFFFL |
3649 |
3657 |
9 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
107 |
NSP6 |
TQWSLFFFL |
3649 |
3657 |
9 |
HLA-B*40:01 |
88.89% (SARS-CoV) |
108 |
NSP6 |
LYENAFLPF |
3657 |
3665 |
9 |
HLA-A*24:02 |
88.89% (SARS-CoV) |
109 |
NSP6 |
FVKHKHAFL |
3679 |
3687 |
9 |
HLA-B*08:01 |
88.89% (SARS-CoV) |
110 |
NSP6 |
FLLPSLATV |
3691 |
3699 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
111 |
NSP6 |
MPASWVMRI |
3707 |
3715 |
9 |
HLA-B*07:02 |
100% (SARS-CoV) |
112 |
NSP6 |
VMYASAVVL |
3735 |
3743 |
9 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
113 |
NSP6 |
MYASAVVLL |
3736 |
3744 |
9 |
HLA-A*24:02 |
88.89% (SARS-CoV) |
114 |
NSP6 |
ILMTARTVY |
3745 |
3753 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
115 |
NSP6 |
ILMTARTVY |
3745 |
3753 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
116 |
NSP6 |
LTLVYKVYY |
3768 |
3776 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
117 |
NSP6 |
LTLVYKVYY |
3768 |
3776 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
118 |
NSP6 |
LIISVTSNY |
3789 |
3797 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
119 |
NSP6 |
LIISVTSNY |
3789 |
3797 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
120 |
NSP6 |
LIISVTSNY |
3789 |
3797 |
9 |
HLA-B*15:01 |
88.89% (SARS-CoV) |
121 |
NSP6 |
MFLARGIVF |
3805 |
3813 |
9 |
HLA-A*24:02 |
88.89% (SARS-CoV) |
122 |
NSP6 |
CYFGLFCLL |
3846 |
3854 |
9 |
HLA-A*24:02 |
100% (SARS-CoV) |
123 |
NSP8 |
EMLDNRATL |
3989 |
3997 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
124 |
NSP8 |
EMLDNRATL |
3989 |
3997 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
125 |
NSP8 |
SLNVAKSEF |
4039 |
4047 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
126 |
NSP8 |
KRAKVTSAM |
4078 |
4086 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
127 |
NSP9 |
LQNNELSPV |
4198 |
4206 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
128 |
NSP9 |
LSDLQDLKW |
4244 |
4252 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
129 |
NSP9 |
LSDLQDLKW |
4244 |
4252 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
130 |
NSP10 |
TELEPPCRF |
4267 |
4275 |
9 |
HLA-B*40:01 |
100% (SARS-CoV), 88.89% (229E) |
131 |
NSP10 |
NNLNRGMVL |
4295 |
4303 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
132 |
RDRP |
RAFDIYNDK |
4488 |
4496 |
9 |
HLA-A*03:01 |
88.89% (SARS-CoV) |
133 |
RDRP |
GERVRQALL |
4636 |
4644 |
9 |
HLA-B*40:01 |
88.89% (SARS-CoV), 88.89% (MERS-CoV) |
134 |
RDRP |
ILHCANFNV |
4766 |
4774 |
9 |
HLA-A*02:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
135 |
RDRP |
LHCANFNVL |
4767 |
4775 |
9 |
HLA-B*39:01 |
100% (SARS-CoV), 100% (MERS-CoV) |
136 |
RDRP |
STVFPPTSF |
4777 |
4785 |
9 |
HLA-A*26:01 |
100% (SARS-CoV) |
137 |
RDRP |
STVFPPTSF |
4777 |
4785 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
138 |
RDRP |
NLHSSRLSF |
4819 |
4827 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
139 |
RDRP |
NLHSSRLSF |
4819 |
4827 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
140 |
RDRP |
SSRLSFKEL |
4822 |
4830 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
141 |
RDRP |
SRLSFKELL |
4823 |
4831 |
9 |
HLA-B*27:05 |
100% (SARS-CoV) |
142 |
RDRP |
SRLSFKELL |
4823 |
4831 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
143 |
RDRP |
LSFKELLVY |
4836 |
4834 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
144 |
RDRP |
LSFKELLVY |
4836 |
4834 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
145 |
RDRP |
LSFKELLVY |
4836 |
4834 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
146 |
RDRP |
LSFKELLVY |
4836 |
4834 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
147 |
RDRP |
LLDKRTTCF |
4848 |
4856 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
148 |
RDRP |
LLDKRTTCF |
4848 |
4856 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
149 |
RDRP |
FKEGSSVEL |
4889 |
4897 |
9 |
HLA-B*39:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
150 |
RDRP |
RQLLFVVEV |
4928 |
4936 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
151 |
RDRP |
FVVEVVDKY |
4932 |
4940 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
152 |
RDRP |
FVVEVVDKY |
4932 |
4940 |
9 |
HLA-A*26:01 |
100% (SARS-CoV) |
153 |
RDRP |
KSAGFPFNK |
4961 |
4969 |
9 |
HLA-A*03:01 |
100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (OC43), 88.89% (HKU1) |
154 |
RDRP |
SYEDQDALF |
4982 |
4990 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 88.89% (NL63) |
155 |
RDRP |
FAYTKRNVI |
4990 |
4998 |
9 |
HLA-B*08:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
156 |
RDRP |
IPTITQMNL |
4998 |
5006 |
9 |
HLA-B*07:02 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
157 |
RDRP |
SAKNRARTV |
5011 |
5019 |
9 |
HLA-B*08:01 |
100% (SARS-CoV), 100% (MERS-CoV), 100% (OC43), 100% (HKU1) |
158 |
RDRP |
ARTVAGVSI |
5016 |
5024 |
9 |
HLA-B*27:05 |
100% (SARS-CoV), 100% (MERS-CoV), 100% (OC43), 100% (HKU1) |
159 |
RDRP |
MTNRQFHQK |
5028 |
5036 |
9 |
HLA-A*03:01 |
100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (229E) |
160 |
RDRP |
VVIGTSKFY |
5050 |
5058 |
9 |
HLA-A*26:01 |
100% (SARS-CoV), 88.89% (NL63), 88/89% (OC43), 88.89% (HKU1), 88.89% (229E) |
161 |
RDRP |
YSDVENPHL |
5069 |
5077 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
162 |
RDRP |
MASLVLARK |
5096 |
5104 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
163 |
RDRP |
AYLRKHFSM |
5212 |
5220 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 88.89% (NL63) |
164 |
RDRP |
YLRKHFSMM |
5213 |
5221 |
9 |
HLA-A*26:01 |
100% (SARS-CoV), 100% (NL63), 88.89% (229E) |
165 |
RDRP |
YLRKHFSMM |
5213 |
5221 |
9 |
HLA-B*07:02 |
100% (SARS-CoV), 100% (NL63), 88.89% (229E) |
166 |
RDRP |
YLRKHFSMM |
5213 |
5221 |
9 |
HLA-B*08:01 |
100% (SARS-CoV), 100% (NL63), 88.89% (229E) |
167 |
RDRP |
YLRKHFSMM |
5213 |
5221 |
9 |
HLA-B*15:01 |
100% (SARS-CoV), 100% (NL63), 88.89% (229E) |
168 |
RDRP |
VLYYQNNVF |
5250 |
5258 |
9 |
HLA-B*15:01 |
100% (SARS-CoV), 100% (OC43), 100% (HKU1), 88.89% (NL63) |
169 |
RDRP |
LYYQNNVFM |
5252 |
5260 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 100% (MERS-CoV), 100% (OC43), 100% (HKU1), 100% (NL63), 88.89% (229E) |
170 |
Helic |
DVFHLYLQY |
5346 |
5354 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
171 |
Helic |
DVFHLYLQY |
5346 |
5354 |
9 |
HLA-A*26:01 |
100% (SARS-CoV) |
172 |
Helic |
HLYLQYIRK |
5349 |
5357 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
173 |
Helic |
GHMLDMYSV |
5364 |
5372 |
9 |
HLA-B*39:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
174 |
Helic |
HMLDMYSVM |
5365 |
5373 |
9 |
HLA-B*39:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
175 |
Helic |
HMLDMYSVM |
5365 |
5373 |
9 |
HLA-B*15:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
176 |
Helic |
WEPEFYEAM |
5383 |
5391 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
177 |
Helic |
LQAVGACVL |
5399 |
5407 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
178 |
Helic |
LQAVGACVL |
5399 |
5407 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
179 |
Helic |
KLVLSVNPY |
5440 |
5448 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
180 |
Helic |
KLVLSVNPY |
5440 |
5448 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
181 |
Helic |
VTDVTQLYL |
5457 |
5465 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
182 |
Helic |
LYLGGMSYY |
5463 |
5471 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 100% (OC43), 100% (HKU1), 88.89% (MERS-CoV) |
183 |
Helic |
REVLSDREL |
5557 |
5565 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
184 |
Helic |
KVQIGEYTF |
5594 |
5602 |
9 |
HLA-A*24:02 |
100% (SARS-CoV) |
185 |
Helic |
KVQIGEYTF |
5594 |
5602 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
186 |
Helic |
KLNVGDYFV |
5621 |
5629 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
187 |
Helic |
TLVPQEHYV |
5642 |
5650 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
188 |
Helic |
VGMQKYSTL |
5675 |
5683 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
189 |
Helic |
SHFAIGLAL |
5693 |
5701 |
9 |
HLA-B*39:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
190 |
Helic |
HFAIGLALY |
5694 |
5702 |
9 |
HLA-A*26:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
191 |
Helic |
FAIGLALYY |
5695 |
5703 |
9 |
HLA-A*01:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
192 |
Helic |
FAIGLALYY |
5695 |
5703 |
9 |
HLA-A*26:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
193 |
Helic |
FAIGLALYY |
5695 |
5703 |
9 |
HLA-B*58:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
194 |
Helic |
ALCEKALKY |
5720 |
5728 |
9 |
HLA-A*03:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
195 |
Helic |
ISMATNYDL |
5781 |
5789 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
196 |
Helic |
VVNARLRAK |
5791 |
5799 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
197 |
Helic |
ARLRAKHYV |
5794 |
5802 |
9 |
HLA-B*27:05 |
100% (SARS-CoV), 88.89% (OC43) |
198 |
Helic |
RLRAKHYVY |
5795 |
5803 |
9 |
HLA-A*03:01 |
100% (SARS-CoV), 88.89% (OC43) |
199 |
Helic |
RLRAKHYVY |
5795 |
5803 |
9 |
HLA-B*08:01 |
100% (SARS-CoV), 88.89% (OC43) |
200 |
Helic |
RLRAKHYVY |
5795 |
5803 |
9 |
HLA-B*15:01 |
100% (SARS-CoV), 88.89% (OC43) |
201 |
Helic |
VYIGDPAQL |
5802 |
5810 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 100% (OC43), 100% (HKU1), 88.89% (MERS-CoV) |
202 |
Helic |
LEPEYFNSV |
5823 |
5831 |
9 |
HLA-B*40:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
203 |
Helic |
RKAVFISPY |
5914 |
5922 |
9 |
HLA-B*27:05 |
100% (SARS-CoV), 88.89%% (MERS-CoV), 88.89% (NL63), 88.89% (OC43), 88.89% (229E) |
204 |
3'-5' |
SSQGSEYDY |
5942 |
5950 |
9 |
HLA-A*01:01 |
100% (SARS-CoV), 100% (NL63), 88.89% (MERS-CoV), 88.89% (HKU1), 88.89% (229E) |
205 |
3'-5' |
ITRAKVGIL |
5973 |
5981 |
9 |
HLA-B*08:01 |
88.89% (SARS-CoV), 88.89% (OC43) |
206 |
3'-5' |
YDKLQFTSL |
5990 |
5998 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
207 |
3'-5' |
DTKFKTEGL |
6040 |
6048 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
208 |
3'-5' |
RLISMMGFK |
6063 |
6071 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
209 |
3'-5' |
LQLGFSTGV |
6118 |
6126 |
9 |
HLA-A*02:01 |
100% (SARS-CoV), 100% (MERS-CoV), 88.89% (OC43), 88.89% (HKU1) |
210 |
3'-5' |
MYKGLPWNV |
6164 |
6172 |
9 |
HLA-A*24:02 |
100% (SARS-CoV) |
211 |
3'-5' |
VVRIKIVQM |
6172 |
6180 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
212 |
3'-5' |
VRIKIVQML |
6173 |
6181 |
9 |
HLA-B*27:05 |
100% (SARS-CoV), 88.89% (HKU1) |
213 |
3'-5' |
VRIKIVQML |
6173 |
6181 |
9 |
HLA-B*39:01 |
100% (SARS-CoV), 88.89% (HKU1) |
214 |
3'-5' |
NLSDRVVFV |
6188 |
6196 |
9 |
HLA-A*02:01 |
88.89% (SARS-CoV) |
215 |
3'-5' |
LSDRVVFVL |
6189 |
6197 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
216 |
3'-5' |
HSIGFDYVY |
6241 |
6249 |
9 |
HLA-A*01:01 |
88.89% (SARS-CoV) |
217 |
3'-5' |
HSIGFDYVY |
6241 |
6249 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
218 |
3'-5' |
HSIGFDYVY |
6241 |
6249 |
9 |
HLA-B*58:01 |
88.89% (SARS-CoV) |
219 |
3'-5' |
HSIGFDYVY |
6241 |
6249 |
9 |
HLA-B*15:01 |
88.89% (SARS-CoV) |
220 |
3'-5' |
GFDYVYNPF |
6244 |
6252 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
221 |
3'-5' |
MIDVQQWGF |
6254 |
6262 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
222 |
3'-5' |
QQWGFTGNL |
6258 |
6266 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
223 |
3'-5' |
QQWGFTGNL |
6258 |
6266 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
224 |
3'-5' |
KIEELFYSY |
6376 |
6384 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
225 |
3'-5' |
YSYATHSDK |
6382 |
6390 |
9 |
HLA-A*03:01 |
88.89% (SARS-CoV) |
226 |
3'-5' |
FVNLKQLPF |
6451 |
6459 |
9 |
HLA-A*26:01 |
88.89% (SARS-CoV) |
227 |
3'-5' |
FVNLKQLPF |
6451 |
6459 |
9 |
HLA-B*08:01 |
88.89% (SARS-CoV) |
228 |
3'-5' |
FVNLKQLPF |
6451 |
6460 |
9 |
HLA-B*15:01 |
88.89% (SARS-CoV) |
229 |
Endo- |
NLKQLPFFY |
6453 |
6461 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
230 |
Endo- |
MMISAGFSL |
6516 |
6524 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
231 |
Endo- |
MMISAGFSL |
6516 |
6524 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
232 |
Endo- |
MMISAGFSL |
6516 |
6524 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
233 |
3'-5' |
MMISAGFSL |
6516 |
6524 |
9 |
HLA-B*40:01 |
100% (SARS-CoV) |
234 |
Endo- |
MMISAGFSL |
6516 |
6524 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
235 |
Endo- |
MISAGFSLW |
6517 |
6525 |
9 |
HLA-B*58:01 |
100% (SARS-CoV) |
236 |
Endo- |
LENVAFNVV |
6546 |
6554 |
9 |
HLA-B*40:01 |
88.89% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (NL63), 88.89% (229E) |
237 |
Endo- |
FENKTTLPV |
6587 |
6595 |
9 |
HLA-B*39:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
238 |
Endo- |
FENKTTLPV |
6587 |
6595 |
9 |
HLA-B*40:01 |
100% (SARS-CoV), 88.89% (MERS-CoV) |
239 |
Endo- |
TTLPVNVAF |
6591 |
6599 |
9 |
HLA-B*58:01 |
100% (SARS-CoV), 88.89% (NL63) |
240 |
Endo- |
TTLPVNVAF |
6592 |
6599 |
9 |
HLA-A*24:02 |
100% (SARS-CoV), 88.89% (NL63) |
241 |
Endo- |
FEHIVYGDF |
6779 |
6787 |
9 |
HLA-B*40:01 |
100% (SARS-CoV), 88.89% (MERS-CoV), 88.89% (OC43) |
242 |
2'-O- |
PMDSTVKNY |
6818 |
6826 |
9 |
HLA-A*01:01 |
100% (SARS-CoV) |
243 |
2'-O- |
ALGGSVAIK |
7059 |
7067 |
9 |
HLA-A*03:01 |
100% (SARS-CoV) |
244 |
2'-O- |
GHFAWWTAF |
7082 |
7090 |
9 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
245 |
2'-O- |
IQLSSYSLF |
7135 |
7143 |
9 |
HLA-A*24:02 |
100% (SARS-CoV) |
246 |
|
IQLSSYSLF |
7135 |
7143 |
9 |
HLA-B*15:01 |
100% (SARS-CoV) |
247 |
|
PLKLRGTAV |
7149 |
7157 |
9 |
HLA-B*08:01 |
100% (SARS-CoV), 88.89% (OC43) |
248 |
|
LRGTAVMSL |
7152 |
7160 |
9 |
HLA-B*39:01 |
100% (SARS-CoV) |
249 |
ORF3a |
IPIQASLPF |
35 |
43 |
10 |
HLA-B*07:02 |
88.89% (SARS-CoV) |
250 |
ORF3a |
APFLYLYAL |
104 |
112 |
9 |
HLA-B*07:02 |
88.89% (SARS-CoV) |
251 |
ORF3a |
LKKRWQLAL |
65 |
73 |
10 |
HLA-B*08:01 |
88.89% (SARS-CoV) |
252 |
ORF3a |
APFLYLYAL |
104 |
112 |
12 |
HLA-B*08:01 |
88.89% (SARS-CoV) |
253 |
ORF3a |
APFLYLYAL |
104 |
112 |
11 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
254 |
ORF6 |
KVSIWNLDY |
23 |
31 |
9 |
HLA-A*01:01 |
55.56% (SARS-CoV) |
255 |
ORF6 |
KVSIWNLDY |
23 |
31 |
10 |
HLA-A*03:01 |
55.56% (SARS-CoV) |
256 |
ORF7a |
ILFLALITL |
4 |
12 |
10 |
HLA-A*02:01 |
66.67% (SARS-CoV) |
257 |
ORF7a |
TLCFTLKRK |
112 |
120 |
10 |
HLA-A*03:01 |
77.78% (SARS-CoV) |
258 |
ORF7a |
VFITLCFTL |
109 |
117 |
10 |
HLA-A*24:02 |
66.67% (SARS-CoV) |
259 |
ORF7a |
MKIILFLAL |
1 |
9 |
9 |
HLA-B*39:01 |
88.89% (SARS-CoV) |
260 |
ORF7a |
ALTCFSTQF |
55 |
63 |
10 |
HLA-B*15:01 |
77.78% (SARS-CoV) |
261 |
ORF7B |
YLCFLAFLL |
10 |
18 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
262 |
ORF7B |
FLAFLLFLV |
13 |
21 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
263 |
ORF7B |
MLIIFWFSL |
24 |
32 |
9 |
HLA-A*02:01 |
100% (SARS-CoV) |
264 |
ORF7B |
IIFWFSLEL |
26 |
34 |
9 |
HLA-A*02:01 |
88.89% (SARS-CoV) |
265 |
ORF7B |
MLIIFWFSL |
24 |
32 |
9 |
HLA-B*08:01 |
100% (SARS-CoV) |
266 |
ORF8 |
SFYEDFLEY |
104 |
112 |
9 |
HLA-A*01:01 |
None |
267 |
ORF8 |
IQYIDIGNY |
72 |
80 |
9 |
HLA-B*15:01 |
None |
268 |
ORF10 |
NVFAFPFTI |
5 |
13 |
9 |
HLA-A*02:01 |
|
269 |
ORF10 |
AFPFTIYSL |
8 |
16 |
9 |
HLA-A*24:02 |
|
270 |
ORF10 |
FPFTIYSLL |
9 |
17 |
9 |
HLA-B*07:02 |
|
271 |
ORF10 |
FPFTIYSLL |
9 |
17 |
9 |
HLA-B*08:01 |
|
272 |
ORF10 |
FPFTIYSLL |
9 |
17 |
9 |
HLA-B*39:01 |
|
273 |
ORF10 |
IAQVDVVNF |
27 |
35 |
10 |
HLA-B*58:01 |
|